Example: Heart Attack

Search clinical trials for: Keyhole-limpet hemocyanin

Total 47 results

NCT01509391

Completed

Keyhole Limpet Hemocyanin in Chronic Hepatitis C

Conditions: Chronic Hepatitis C; Liver Cirrhosis
NCT00006034

Completed

Keyhole Limpet Hemocyanin Compared With Doxorubicin in Treating Patients With Bladder Cancer

Conditions: Bladder Cancer
NCT00470574

Completed

Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer

Conditions: Breast Cancer
NCT01489956

Terminated

A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)

Conditions: Autoimmune Disorders
NCT00026624

Completed

Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC

Conditions: HIV Infections
NCT00369291

Terminated

CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant

Conditions: Germ Cell Tumor; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm
NCT00614731

Completed

Responses to Immunization With Keyhole Limpet Hemocyanin Administered by Scarification and the Intradermal Route

Conditions: Atopic Dermatitis
NCT02079480

Terminated

Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects

Conditions: Healthy Adult Volunteers
NCT00536120

Completed

The Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis

Conditions: Multiple Sclerosis
NCT00019097

Completed

Vaccine Therapy in Treating Patients With Multiple Myeloma

Conditions: Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell Neoplasm
NCT01910662

Completed

Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD)

Conditions: Dermatitis
NCT00004249

Completed

Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy

Conditions: Lung Cancer
NCT00050921

Completed

Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs

Conditions: HIV Infections
NCT00000105

Terminated

Vaccination With Tetanus and KLH to Assess Immune Responses.

Conditions: Cancer
NCT00003819

Completed

Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer

Conditions: Prostate Cancer
NCT00004198

Completed

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma

Conditions: Lymphoma
NCT00004156

Completed

Vaccine Therapy in Treating Patients With Breast Cancer

Conditions: Breast Cancer
NCT00006478

Terminated

Vaccine Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma

Conditions: Lymphoma
NCT00003638

Completed

Vaccine Therapy in Treating Women With Metastatic Breast Cancer

Conditions: Breast Cancer
NCT02947854

Completed

Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant

Conditions: Healthy Volunteer
NCT02754362

Withdrawn

A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent Glioblastoma

Conditions: Glioblastoma; Glioma
NCT02745756

Withdrawn

A Combined Cell Therapy Approach to the Treatment of Neuroblastoma

Conditions: Neuroblastoma; Neoplasms, Nerve Tissue
NCT00093522

Unknown status

Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer

Conditions: Kidney Cancer
NCT01082198

Unknown status

Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes

Conditions: Melanoma (Skin)
NCT00030823

Completed

Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence

Conditions: Breast Cancer